Table 1 Background of gastric cancer patients with serum TFF3 analysis

Age

 ≤60

44

12.72 ± 1.21

0.0529

 >60

46

20.29 ± 3.59

Gender

 Male

75

16.65 ± 2.28

0.9489

 Female

15

16.31 ± 2.90

Site

 Fundus/Cardia

35

13.96 ± 1.18

 Gastric body

22

20.28 ± 7.43

0.323

 Antrum

30

16.92 ± 1.69

Degree of differentiation

 Well-moderately

41

13.10 ± 1.27

0.1034

 Poorly

49

19.51 ± 3.40

Stage

(I-III VS IV)

0.0017

 I

9

8.89 ± 1.35

 II

9

12.94 ± 2.24

 III

29

12.07 ± 0.73

 IV

43

22.02 ± 3.89

Lymphatic metastasis

 N(-)

13

10.71 ± 1.01

0.3057

 N(+)

33

12.23 ± 0.83

  N1

12

12.91 ± 1.81

  N2

7

11.84 ± 1.98

0.9603

  N3

4

11.85 ± 0.82

Distant metastasis

 M0

48

11.97 ± 0.76

0.0108

 M1

42

21.88 ± 3.97